JCR pharmaceuticals logo. Click here to go to the home page
  • Visit JCR Japan
  • Visit JCR Japan
  • Home
  • Who we are
  • Innovation
  • Pipeline
  • Patients & families
  • Our commitment
  • Partnerships
  • Investors & media
  • Our products
  • Contact us

Copyright 2025, JCR Pharmaceuticals Co., Ltd. All Rights Reserved

Reports

FY2024 results briefing session

Watch video (external)


by Moises Zanetti

FY2024 results briefing session script


by Moises Zanetti

[Delayed] Notice of recognition of gain on deferred income taxes


by Moises Zanetti

FY2024 results briefing session material


by Moises Zanetti

Financial summary consolidated financial results for the year ended March 31, 2025 (FY2024) (Japanese standard)


by Moises Zanetti

Notice of distribution of retained earnings


by Moises Zanetti

JCR revises full-year consolidated forecast for FY2024


by Moises Zanetti

Notice of partial correction to “FY2024 third quarter consolidated financial results conference call material”


by Moises Zanetti

FY2024 third quarter consolidated financial results conference call scrip

February 4, 2025

FY2024 third quarter consolidated financial results conference call material


by Moises Zanetti

  • 1
  • 2
  • 3
Contact us
JCR pharmaceuticals logo. Click here to go to the home page

  • Sitemap
  • Compliance
  • Privacy policy
  • Global policy
  • Cookie policy
  • Cookie settings

Copyright 2025, JCR Pharmaceuticals Co., Ltd. All Rights Reserved

Privacy Preference Center

Privacy Preferences